This inventor holds 2 USPTO granted patents. Top assignee: National Institute of Health and Medical Research. Active years: 1999.
Company Filing History:
Years Active: 1999
Title: Martine Charon: Innovator in Molecular Detection
Introduction
Martine Charon is a prominent inventor based in Paris, France. She has made significant contributions to the field of molecular detection, particularly in the area of growth factor receptors. With a total of 2 patents, her work has implications for both research and clinical applications.
Latest Patents
Martine Charon's latest patents include innovative methods for the detection of molecules with affinity for MPL polypeptides. One of her notable inventions is a polypeptide of a growth factor receptor family, which has a specific sequence and presents properties that encourage and/or are involved in the proliferation and/or differentiation of hematopoietic cell lines when obtained from the MPLV retrovirus. This polypeptide is capable of acting as a hematopoietic growth factor receptor and is recognized by antibodies directed against it. Additionally, she has developed nucleic acids encoding polypeptides of a growth factor receptor family, which have applications in diagnosing the expression of said ligand polypeptide.
Career Highlights
Martine Charon is affiliated with the National Institute of Health and Medical Research, where she continues to advance her research. Her work has garnered attention for its potential to impact the understanding of hematopoietic cell lines and their applications in medicine.
Collaborations
Martine has collaborated with esteemed colleagues, including Isabelle Vigon and Francoise Wendling, contributing to a dynamic research environment that fosters innovation.
Conclusion
Martine Charon's contributions to molecular detection and growth factor receptors highlight her role as a leading inventor in her field. Her patents reflect a commitment to advancing scientific knowledge and improving diagnostic methods.